I2760

(−)-Isoproterenol -(+)-bitartratsalz

powder

• Synonym(e): (−)-Isoprenalin -(+)-bitartratsalz
• Empirische Formel (Hill-System): C₁₁H₁₇NO₃ · C₄H₆O₆
• CAS-Nummer: 54750-10-6
• Molekulargewicht: 361.34
• MDL-Nummer: MFCD00069361
• UNSPSC-Code: 51111800
• PubChem Substanz-ID: 24277773
• NACRES: NA.77

Eigenschaften

• Form: powder
• Qualitätsniveau: 200
• Farbe: white to off-white
• Löslichkeit: H₂O: ≥50 mg/mL, clear, colorless to faintly yellow
• Ersteller: Sanofi Aventis
• SMILES String: O[C@@H]([C@H](O)C(O)=O)C(O)=O.CC(C)NC[C@H](O)c1ccc(O)c(O)c1
• InChI: 1S/C11H17NO3.C4H6O6/c1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8;5-1(3(7)8)2(6)4(9)10/h3-5,7,11-15H,6H2,1-2H3;1-2,5-6H,(H,7,8)(H,9,10)/t11-;1-,2-/m00/s1
• InChIKey: LBOPECYONBDFEM-RWALOXMOSA-N
• Angaben zum Gen: human ... ADRB1(153) , ADRB2(154) , ADRB3(155)

Beschreibung

Anwendung

(−)-Isoproterenol (+)-bitartrate salt has been used:

• as a component in KRH medium for cyclic adenosine monophosphate (cAMP) assay
• to stimulate preadipocytes to study its concentration responsive curve
• to intraperitoneally administer to mice to evaluate whether the multi-dry-electrode plate (MDEP)-sensor system can assess drug responses

Biochem./physiol. Wirkung

Isoproterenol functions as an ovine pulmonary vein dilator.

β-Adrenoceptor-Agonist; erhöht cytosolisches cAMP.

Leistungsmerkmale und Vorteile

This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Sicherheitshinweise

• Piktogramme: GHS07
• Signalwort: Warning
• H-Sätze: H315,H319,H335
• P-Sätze: P261 - P305 + P351 + P338
• Gefahreneinstufungen: Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3